| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Abnormality of refraction | 8.05e-05 | 709 | 10 | 7 | HP:0000539 | |
| HumanPheno | Abnormal penis morphology | 8.28e-05 | 712 | 10 | 7 | HP:0000036 | |
| HumanPheno | Posteriorly rotated ears | 9.09e-05 | 470 | 10 | 6 | HP:0000358 | |
| HumanPheno | Cryptorchidism | 1.51e-04 | 780 | 10 | 7 | HP:0000028 | |
| HumanPheno | Strabismus | 2.03e-04 | 1159 | 10 | 8 | HP:0000486 | |
| HumanPheno | Cataract | 2.13e-04 | 822 | 10 | 7 | HP:0000518 | |
| HumanPheno | Abnormal lens morphology | 2.40e-04 | 837 | 10 | 7 | HP:0000517 | |
| HumanPheno | Abnormal conjugate eye movement | 2.60e-04 | 1198 | 10 | 8 | HP:0000549 | |
| HumanPheno | Agenesis of corpus callosum | 3.43e-04 | 365 | 10 | 5 | HP:0001274 | |
| Domain | LisH | 1.18e-03 | 28 | 34 | 2 | IPR006594 | |
| Domain | LisH | 1.18e-03 | 28 | 34 | 2 | SM00667 | |
| Domain | LISH | 1.18e-03 | 28 | 34 | 2 | PS50896 | |
| Domain | PDZ | 2.12e-03 | 141 | 34 | 3 | PF00595 | |
| Domain | AAA+_ATPase | 2.25e-03 | 144 | 34 | 3 | IPR003593 | |
| Domain | AAA | 2.25e-03 | 144 | 34 | 3 | SM00382 | |
| Domain | PDZ | 2.44e-03 | 148 | 34 | 3 | SM00228 | |
| Domain | - | 2.53e-03 | 150 | 34 | 3 | 2.30.42.10 | |
| Domain | PDZ | 2.58e-03 | 151 | 34 | 3 | PS50106 | |
| Domain | PDZ | 2.63e-03 | 152 | 34 | 3 | IPR001478 | |
| Domain | Collagen | 1.04e-02 | 85 | 34 | 2 | PF01391 | |
| Domain | Collagen | 1.04e-02 | 85 | 34 | 2 | IPR008160 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.35e-05 | 53 | 22 | 3 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.29e-04 | 64 | 22 | 3 | M26953 | |
| Pubmed | Inverse Correlation of TRIM32 and Protein Kinase C ζ in T Helper Type 2-Biased Inflammation. | 1.10e-06 | 2 | 37 | 2 | 33096083 | |
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 15007166 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 20833135 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 26586575 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 21940993 | ||
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 17185750 | ||
| Pubmed | 1.55e-05 | 777 | 37 | 7 | 35844135 | ||
| Pubmed | Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. | 1.65e-05 | 6 | 37 | 2 | 21419114 | |
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 2.30e-05 | 7 | 37 | 2 | 23415230 | |
| Pubmed | Expression pattern of Nav2 in the murine CNS with development. | 2.30e-05 | 7 | 37 | 2 | 32081718 | |
| Pubmed | 3.84e-05 | 360 | 37 | 5 | 33111431 | ||
| Pubmed | Radial WNT5A-Guided Post-mitotic Filopodial Pathfinding Is Critical for Midgut Tube Elongation. | 3.95e-05 | 9 | 37 | 2 | 30016620 | |
| Pubmed | Essential role of PDZ-RGS3 in the maintenance of neural progenitor cells. | 3.95e-05 | 9 | 37 | 2 | 20629178 | |
| Pubmed | KIF20A/MKLP2 regulates the division modes of neural progenitor cells during cortical development. | 3.95e-05 | 9 | 37 | 2 | 30006548 | |
| Pubmed | The anaphase-promoting complex coordinates initiation of lens differentiation. | 3.95e-05 | 9 | 37 | 2 | 17215516 | |
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 33993983 | ||
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 24788519 | ||
| Pubmed | 5.04e-05 | 1285 | 37 | 8 | 35914814 | ||
| Pubmed | 6.02e-05 | 11 | 37 | 2 | 22885183 | ||
| Pubmed | Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma. | 6.02e-05 | 11 | 37 | 2 | 28827401 | |
| Pubmed | 7.22e-05 | 12 | 37 | 2 | 25916881 | ||
| Pubmed | GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells. | 7.22e-05 | 12 | 37 | 2 | 34699385 | |
| Pubmed | 8.14e-05 | 216 | 37 | 4 | 31519766 | ||
| Pubmed | 8.40e-05 | 1014 | 37 | 7 | 32416067 | ||
| Pubmed | 8.53e-05 | 13 | 37 | 2 | 16571631 | ||
| Pubmed | 8.53e-05 | 13 | 37 | 2 | 19100728 | ||
| Pubmed | WDR1-regulated actin dynamics is required for outflow tract and right ventricle development. | 8.53e-05 | 13 | 37 | 2 | 29654745 | |
| Pubmed | ECM-integrin signalling instructs cellular position sensing to pattern the early mouse embryo. | 8.53e-05 | 13 | 37 | 2 | 34908109 | |
| Pubmed | 9.94e-05 | 14 | 37 | 2 | 27974163 | ||
| Pubmed | Pericyte ALK5/TIMP3 Axis Contributes to Endothelial Morphogenesis in the Developing Brain. | 9.94e-05 | 14 | 37 | 2 | 29456135 | |
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 26035863 | ||
| Pubmed | Synaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis. | 1.15e-04 | 15 | 37 | 2 | 35927244 | |
| Pubmed | A genome-wide association study on obesity and obesity-related traits. | 1.15e-04 | 15 | 37 | 2 | 21552555 | |
| Pubmed | Lgl1 deficiency disrupts hippocampal development and impairs cognitive performance in mice. | 1.31e-04 | 16 | 37 | 2 | 31415124 | |
| Pubmed | EMC3 Is Essential for Retinal Organization and Neurogenesis During Mouse Retinal Development. | 1.31e-04 | 16 | 37 | 2 | 33605987 | |
| Pubmed | 1.31e-04 | 16 | 37 | 2 | 22542185 | ||
| Pubmed | MALS-3 regulates polarity and early neurogenesis in the developing cerebral cortex. | 1.48e-04 | 17 | 37 | 2 | 18403412 | |
| Pubmed | 1.48e-04 | 17 | 37 | 2 | 23197712 | ||
| Pubmed | Huntingtin regulates mammary stem cell division and differentiation. | 1.67e-04 | 18 | 37 | 2 | 24749073 | |
| Pubmed | Hemidesmosome integrity protects the colon against colitis and colorectal cancer. | 1.67e-04 | 18 | 37 | 2 | 27371534 | |
| Pubmed | 1.67e-04 | 18 | 37 | 2 | 27412481 | ||
| Pubmed | 1.70e-04 | 494 | 37 | 5 | 26831064 | ||
| Pubmed | 1.82e-04 | 103 | 37 | 3 | 32744500 | ||
| Pubmed | 1.85e-04 | 503 | 37 | 5 | 16964243 | ||
| Pubmed | ILK modulates epithelial polarity and matrix formation in hair follicles. | 1.86e-04 | 19 | 37 | 2 | 24371086 | |
| Pubmed | 1.86e-04 | 19 | 37 | 2 | 19666823 | ||
| Pubmed | 1.95e-04 | 809 | 37 | 6 | 32129710 | ||
| Pubmed | Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development. | 2.07e-04 | 20 | 37 | 2 | 21606200 | |
| Pubmed | The APC/C activator FZR1 is essential for meiotic prophase I in mice. | 2.07e-04 | 20 | 37 | 2 | 24553289 | |
| Pubmed | 2.28e-04 | 21 | 37 | 2 | 19217427 | ||
| Pubmed | Neural tube opening and abnormal extraembryonic membrane development in SEC23A deficient mice. | 2.28e-04 | 21 | 37 | 2 | 26494538 | |
| Pubmed | 2.51e-04 | 22 | 37 | 2 | 35089129 | ||
| Pubmed | The apical complex couples cell fate and cell survival to cerebral cortical development. | 2.51e-04 | 22 | 37 | 2 | 20399730 | |
| Pubmed | MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. | 2.51e-04 | 22 | 37 | 2 | 34032267 | |
| Pubmed | 2.51e-04 | 22 | 37 | 2 | 22705452 | ||
| Pubmed | 2.52e-04 | 538 | 37 | 5 | 28524877 | ||
| Pubmed | 2.72e-04 | 118 | 37 | 3 | 30979931 | ||
| Pubmed | MicroRNA-124 Regulates Cell Specification in the Cochlea through Modulation of Sfrp4/5. | 2.75e-04 | 23 | 37 | 2 | 26387953 | |
| Pubmed | 2.75e-04 | 23 | 37 | 2 | 16267237 | ||
| Pubmed | 2.75e-04 | 23 | 37 | 2 | 25523391 | ||
| Pubmed | 2.75e-04 | 23 | 37 | 2 | 31504280 | ||
| Pubmed | 2.79e-04 | 298 | 37 | 4 | 30737378 | ||
| Pubmed | 3.52e-04 | 26 | 37 | 2 | 24478334 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 3.61e-04 | 130 | 37 | 3 | 35545047 | |
| Pubmed | 3.80e-04 | 27 | 37 | 2 | 27178982 | ||
| Pubmed | 4.09e-04 | 28 | 37 | 2 | 35666215 | ||
| Pubmed | 4.09e-04 | 28 | 37 | 2 | 38324473 | ||
| Pubmed | Cell dynamics in fetal intestinal epithelium: implications for intestinal growth and morphogenesis. | 4.09e-04 | 28 | 37 | 2 | 21880782 | |
| Pubmed | 4.35e-04 | 335 | 37 | 4 | 15741177 | ||
| Pubmed | HAND2-mediated epithelial maintenance and integrity in cardiac outflow tract morphogenesis. | 4.39e-04 | 29 | 37 | 2 | 31201155 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.91e-04 | 1353 | 37 | 7 | 29467282 | |
| Pubmed | BCAS2 is involved in alternative mRNA splicing in spermatogonia and the transition to meiosis. | 5.02e-04 | 31 | 37 | 2 | 28128212 | |
| Pubmed | 5.02e-04 | 31 | 37 | 2 | 20930145 | ||
| Pubmed | 5.02e-04 | 31 | 37 | 2 | 22274697 | ||
| Pubmed | 5.35e-04 | 32 | 37 | 2 | 25715394 | ||
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 5.35e-04 | 32 | 37 | 2 | 15848144 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.58e-04 | 358 | 37 | 4 | 32460013 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 5.93e-04 | 364 | 37 | 4 | 24778252 | |
| Pubmed | 6.50e-04 | 159 | 37 | 3 | 30581152 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 6.84e-04 | 670 | 37 | 5 | 22990118 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 7.16e-04 | 37 | 37 | 2 | 36835656 | |
| Pubmed | 7.56e-04 | 38 | 37 | 2 | 25572963 | ||
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 7.96e-04 | 39 | 37 | 2 | 16510873 | |
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 7.96e-04 | 39 | 37 | 2 | 21606205 | |
| Pubmed | 8.35e-04 | 399 | 37 | 4 | 35987950 | ||
| Pubmed | 8.37e-04 | 40 | 37 | 2 | 32317081 | ||
| Pubmed | 8.87e-04 | 177 | 37 | 3 | 26206133 | ||
| Pubmed | Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation. | 9.23e-04 | 42 | 37 | 2 | 26362536 | |
| Pubmed | 9.23e-04 | 42 | 37 | 2 | 23863479 | ||
| Pubmed | 1.00e-03 | 730 | 37 | 5 | 34857952 | ||
| Pubmed | 1.01e-03 | 44 | 37 | 2 | 34815802 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q32 | 2.80e-03 | 97 | 37 | 2 | chr7q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 3.40e-03 | 107 | 37 | 2 | chr11q22 | |
| GeneFamily | PDZ domain containing | 1.04e-03 | 152 | 24 | 3 | 1220 | |
| GeneFamily | Collagens | 1.69e-03 | 46 | 24 | 2 | 490 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 1.38e-05 | 226 | 36 | 5 | M11238 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-05 | 169 | 37 | 4 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-05 | 192 | 37 | 4 | 86d561c30554ff04c21801d4aaf8e3c9efe49af4 | |
| ToppCell | COVID-19_Severe-Myeloid_G-immature_Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 1.90e-05 | 192 | 37 | 4 | 303deb68da2e4a75e6ee5a79478182a8bc41c7c5 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.90e-05 | 192 | 37 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 193 | 37 | 4 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 194 | 37 | 4 | bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 195 | 37 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 195 | 37 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 197 | 37 | 4 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.10e-05 | 197 | 37 | 4 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-05 | 198 | 37 | 4 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.14e-05 | 198 | 37 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 2.19e-05 | 199 | 37 | 4 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 2.19e-05 | 199 | 37 | 4 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 37 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.23e-05 | 200 | 37 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 142 | 37 | 3 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 142 | 37 | 3 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-04 | 146 | 37 | 3 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 153 | 37 | 3 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 154 | 37 | 3 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 159 | 37 | 3 | 555ebf719504980c7584203a3ee1ba5779ab76d8 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 159 | 37 | 3 | a6a5cded6da02a112e04c2c71ce08cc27c1c5002 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-04 | 163 | 37 | 3 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 167 | 37 | 3 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-04 | 168 | 37 | 3 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-04 | 168 | 37 | 3 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-04 | 168 | 37 | 3 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 168 | 37 | 3 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.68e-04 | 169 | 37 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-04 | 169 | 37 | 3 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.75e-04 | 170 | 37 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-04 | 170 | 37 | 3 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 170 | 37 | 3 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-04 | 171 | 37 | 3 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.88e-04 | 172 | 37 | 3 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.94e-04 | 173 | 37 | 3 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.94e-04 | 173 | 37 | 3 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.01e-04 | 174 | 37 | 3 | 02ab165b064acb91f2d3f59cc5be195899d61a83 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 4.01e-04 | 174 | 37 | 3 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | facs-Marrow-T_cells-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 175 | 37 | 3 | d3d574962c0a4a0d64db120320f0d04e11d2c9d8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 175 | 37 | 3 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | facs-Marrow-T_cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 175 | 37 | 3 | 4d77fade9ab87b79ac206d074b0e2ef8930c044e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 175 | 37 | 3 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 175 | 37 | 3 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-04 | 177 | 37 | 3 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.22e-04 | 177 | 37 | 3 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | droplet-Marrow|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 177 | 37 | 3 | 0b8a1496c078874def0bfca0268136f1a84b82fd | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-04 | 178 | 37 | 3 | 40bd605b801d9ae76cffc8f62836092fc2b06812 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-04 | 178 | 37 | 3 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.36e-04 | 179 | 37 | 3 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-04 | 179 | 37 | 3 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-04 | 181 | 37 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-04 | 182 | 37 | 3 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.65e-04 | 183 | 37 | 3 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.65e-04 | 183 | 37 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-04 | 184 | 37 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-04 | 184 | 37 | 3 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 4.72e-04 | 184 | 37 | 3 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 4.72e-04 | 184 | 37 | 3 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-04 | 184 | 37 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-04 | 184 | 37 | 3 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 185 | 37 | 3 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | 2ca0b6c590c1e18122d18a728586fbd8c0024dc4 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.87e-04 | 186 | 37 | 3 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 4.87e-04 | 186 | 37 | 3 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 186 | 37 | 3 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 186 | 37 | 3 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.95e-04 | 187 | 37 | 3 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-04 | 187 | 37 | 3 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-04 | 187 | 37 | 3 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.95e-04 | 187 | 37 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 4.95e-04 | 187 | 37 | 3 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-04 | 187 | 37 | 3 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-04 | 187 | 37 | 3 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.95e-04 | 187 | 37 | 3 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-04 | 187 | 37 | 3 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 5.02e-04 | 188 | 37 | 3 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.02e-04 | 188 | 37 | 3 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-04 | 188 | 37 | 3 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-04 | 188 | 37 | 3 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 188 | 37 | 3 | a6ad6de6aeaf213952124252c1452b73942a0c3d | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 5.02e-04 | 188 | 37 | 3 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-04 | 188 | 37 | 3 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.10e-04 | 189 | 37 | 3 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.10e-04 | 189 | 37 | 3 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.10e-04 | 189 | 37 | 3 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-04 | 189 | 37 | 3 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.10e-04 | 189 | 37 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.10e-04 | 189 | 37 | 3 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.10e-04 | 189 | 37 | 3 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 190 | 37 | 3 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-04 | 190 | 37 | 3 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-04 | 190 | 37 | 3 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-04 | 190 | 37 | 3 | 638bebe200249ff6f7be764d89bd762da39ebaae | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.18e-04 | 190 | 37 | 3 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| Computational | Neighborhood of FANCG | 1.81e-05 | 167 | 22 | 5 | MORF_FANCG | |
| Disease | migraine disorder, pulse pressure measurement | 4.88e-04 | 26 | 37 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | coronary aneurysm | 8.87e-04 | 35 | 37 | 2 | EFO_1000881 | |
| Disease | fibrinogen measurement, coronary artery disease | 9.51e-04 | 154 | 37 | 3 | EFO_0001645, EFO_0004623 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.40e-03 | 44 | 37 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 1.53e-03 | 46 | 37 | 2 | EFO_0008003, GO_0097332 | |
| Disease | Psoriasis | 2.34e-03 | 57 | 37 | 2 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 2.34e-03 | 57 | 37 | 2 | C0030246 | |
| Disease | Disorder of eye | 2.37e-03 | 212 | 37 | 3 | C0015397 | |
| Disease | blood osmolality measurement | 2.42e-03 | 58 | 37 | 2 | EFO_0007967 | |
| Disease | Liver Cirrhosis, Experimental | 2.67e-03 | 774 | 37 | 5 | C0023893 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.85e-03 | 63 | 37 | 2 | EFO_0001645, EFO_0004792 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 3.60e-03 | 71 | 37 | 2 | EFO_0001645, EFO_0004791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAGTPRGKKMADPEM | 386 | Q96MC4 | |
| MGSSPPKSKDMDNEG | 571 | Q8IYX3 | |
| MKMPTFSTPGAKGEG | 631 | Q09666 | |
| VKMPKFSMPGFKGEG | 2641 | Q09666 | |
| VKMPKFSMPGFKGEG | 4191 | Q09666 | |
| KMSMTGAGKSPPSVQ | 131 | Q96KQ7 | |
| LPGKPGSMDKVDMGS | 931 | P02462 | |
| MGMKVPGKGESGPSA | 1 | Q6PCT2 | |
| MKKPRCGVPDSGGFM | 86 | P22894 | |
| GAPPAGKADKMMKSF | 1046 | P49796 | |
| SSSPSKPSSEMGGKM | 76 | O60721 | |
| MGKGDPNKPRGKMSS | 1 | P26583 | |
| TGDMMPKGPQGQKSL | 1051 | A9Z1Z3 | |
| TGGLSIKGKTTMPGM | 266 | Q8NDH3 | |
| PTGDGKSMKAFMESP | 1666 | P46013 | |
| MKKIPEMLFSETGGG | 2816 | Q8NCM8 | |
| LMGMPTGLPSGGEAK | 2691 | Q3L8U1 | |
| MEKFGMNFGGGPSKK | 1 | Q96CN9 | |
| GAGMSTAMGRSPSPK | 156 | Q16666 | |
| AGKGSMIAAPDPEKM | 156 | Q9NTJ4 | |
| KMISAGLPGEMGSPG | 1696 | A6NMZ7 | |
| ASPMKKPFGFRGKMG | 11 | Q6S8J7 | |
| CSGPDKVMKVMGSGP | 861 | Q8ND04 | |
| SGGMSKPLMRAPASG | 946 | Q8NET4 | |
| MFEEKASSPSGKMGG | 1 | P26639 | |
| MVGPPGTGKTMLAKA | 246 | Q9BW62 | |
| MGAKGSTPGMFNLPV | 361 | Q13049 | |
| MGDDGSPPAKKMITD | 21 | P12757 | |
| GKSPQVKPASTMGMG | 501 | Q13428 | |
| VKPASTMGMGPLGKG | 506 | Q13428 | |
| GTKKDSGMVPMTGFT | 501 | Q9UL63 | |
| SSSSGMVPKLPAGKM | 481 | Q9HDB5 | |
| APSHSGIPKPGMKSM | 581 | Q8IVL1 | |
| HSMDSMLPSGEGGPK | 461 | O00327 | |
| KMPLFGASAPGKSME | 681 | Q8IVF2 | |
| GKPPHSSIMSMATGK | 1141 | Q12767 | |
| SPTIKKMPGGMIHFS | 296 | Q8N3Z0 | |
| STGPMKIFRGAPGTM | 2371 | Q96AY4 | |
| SAGGMGQKPVEMSGK | 86 | Q5T619 | |
| VMGKSPMGHKPSSSQ | 216 | Q2WGJ8 | |
| MPSRTGPKMEGSGGR | 1 | Q05513 |